Stakeholders in psychiatry and their attitudes toward receiving pertinent and incident findings in genomic research

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

DOI

  • Anna Sundby
  • Merete Watt Boolsen, Department of Political Science, Copenhagen University, Copenhagen, Denmark, Denmark
  • Kristoffer Solvsten Burgdorf, Department of Clinical Immunology, Copenhagen University Hospital, Copenhagen, Denmark.
  • ,
  • Henrik Ullum, Department of Clinical Immunology, Copenhagen University Hospital, Copenhagen, Denmark., Denmark
  • Thomas F Hansen, The Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH), Aarhus, Denmark, Institute for Biological Psychiatry, Mental Health Centre Sct. Hans, Copenhagen University Hospital, Copenhagen, Denmark, Denmark
  • Anna Middleton, Society and Ethics Research, Connecting Science, Wellcome Genome Campus, Cambridge, United Kingdom, United Kingdom
  • Ole Mors
Increasingly more psychiatric research studies use whole genome sequencing or whole exome sequencing. Consequently, researchers face difficult questions, such as which genomic findings to return to research participants and how. This study aims to gain more knowledge on the attitudes among potential research participants and health professionals toward receiving pertinent and incidental findings. A cross-sectional online survey was developed to investigate the attitudes among research participants toward receiving genomic findings. A total of 2,637 stakeholders responded: 241 persons with mental disorders, 671 relatives, 1,623 blood donors, 74 psychiatrists, and 28 clinical geneticists. Stakeholders wanted both pertinent findings (95%) and incidental findings (91%) to be made available for research participants. The majority (77%) stated that researchers should not actively search for incidental findings. Persons with mental disorders and relatives were generally more positive about receiving any kind of findings than clinical geneticists and psychiatrists. Compared with blood donors, persons with mental disorders reported to be more positive about receiving raw genomic data and information that is not of serious health importance. Psychiatrists and clinical geneticists were less positive about receiving genomic findings compared with blood donors. The attitudes toward receiving findings were very positive. Stakeholders were willing to refrain from receiving incidental information if it could compromise the research. Our results suggest that research participants consider themselves as altruistic participants. This study offers valuable insight, which may inform future programs aiming to develop new strategies to target issues relating to the return of findings in genomic research.
Original languageEnglish
JournalAmerican Journal of Medical Genetics. Part A
Volume173
Issue10
Pages (from-to)2649-2658
Number of pages10
ISSN1552-4825
DOIs
Publication statusPublished - 17 Aug 2017

See relations at Aarhus University Citationformats

ID: 115899383